February 2018 Innovation Gateway Highlights

  • UGA startup ArunA Biomedical launched a new class of cell-free exosome biologics to treat central nervous system and neurodegenerative disorders.
  • Innovation Gateway executed a testing agreement with a golf course for experimental bermudagrass lines developed by Brian Schwartz, department of crop and soil sciences.
  • UGA startup Lectenz® Bio was awarded a SBIR Phase II grant from NIH to further develop its high-specificity affinity reagents.
    • Lectenz® Bio is also seeking a Lab Manager and a Research Scientist to join their team in Athens to develop novel technologies and services in glycoscience that advance research and clinical applications.
  • Innovation Gateway and Abcam entered into a non-exclusive agreement for a versatile monoclonal antibody developed in the lab of Richard Meagher, department of genetics.
  • Innovation Gateway executed a non-exclusive license agreement for a blueberry cultivar developed by Scott NeSmith, department of horticulture.
  • An Innovation Gateway staff member presented on intellectual property and licensing to students enrolled in the “Introduction to Bioinformatics” class offered by UGA’s Institute of Bioinformatics.
  • Innovation Gateway was an exhibitor at the Southeast Regional Fruit and Vegetable Conference in Savannah, GA.
  • Kerafast launched five new products originating from research developed in the laboratories of Mark Brown and Michael Strand, department of entomology.
  • Innovation Gateway met with company representatives interested in a research collaboration with UGA to produce and process a potential new crop in Georgia.
  • The Spring 2018 UGA I-Corps cohort launched and features six teams interested in transitioning their innovations into the marketplace.
  • Innovation Gateway and Kerafast entered into a series of license agreements for multiple enzymes produced by UGA’s BioExpression and Fermentation Facility.
  • Follow us on LinkedIn and Twitter!